Repligen board OKs stock buyback plan
By
Associated Press
June 18, 2008
|
Repligen Corp. said Wednesday its board authorized the repurchase of up to 1.3 million shares in the open market or private transactions.
The biopharmaceutical company has 31.2 million shares outstanding, and the stock repurchases will be funded with available cash.
In afternoon trading, Repligen shares rose 21 cents, or 4.4 percent, to $4.96.